USFDA inspects Divis Laboratories’ Unit-I at Hyderabad

21 Jun 2014 Evaluate

Divis Laboratories’ Unit-I at Lingojigudem village, Choutuppal Mandal near Hyderabad has been successfully inspected by the USFDA from June 16-20, 2014, without any observations. The purpose of this inspection was for general Current Good Manufacturing Practices for the facility.

Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.

Divis Lab Share Price

6011.85 -60.75 (-1.00%)
23-Jan-2026 13:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.00
Dr. Reddys Lab 1238.70
Cipla 1323.65
Zydus Lifesciences 884.50
Lupin 2141.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×